Published in Resuscitation on November 11, 2011
Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2015) 2.16
Early oxygenation and ventilation measurements after pediatric cardiac arrest: lack of association with outcome. Crit Care Med (2013) 2.08
Shorter time to target temperature is associated with poor neurologic outcome in post-arrest patients treated with targeted temperature management. Resuscitation (2014) 1.58
Targeted temperature management after out-of-hospital cardiac arrest: who, when, why, and how? Can Fam Physician (2015) 1.39
Therapeutic hypothermia after cardiac arrest: outcome predictors. Rev Bras Ter Intensiva (2016) 1.08
Neurocritical care update. J Intensive Care (2016) 1.00
A Cerebral Recovery Index (CRI) for early prognosis in patients after cardiac arrest. Crit Care (2013) 0.97
Association of left ventricular systolic function and vasopressor support with survival following pediatric out-of-hospital cardiac arrest. Pediatr Crit Care Med (2015) 0.91
Determinants of heat generation in patients treated with therapeutic hypothermia following cardiac arrest. J Am Heart Assoc (2014) 0.80
Survival and neurologic outcomes of out-of-hospital cardiac arrest patients who were transferred after return of spontaneous circulation for integrated post-cardiac arrest syndrome care: the another feasibility of the cardiac arrest center. J Korean Med Sci (2014) 0.79
Spontaneous cooling and rewarming after cardiac arrest may not be therapeutic. Resuscitation (2012) 0.75
Serum proteomics as a strategy to identify novel biomarkers of neurologic recovery after cardiac arrest: a feasibility study. Intensive Care Med Exp (2016) 0.75
Cooling techniques for targeted temperature management post-cardiac arrest. Crit Care (2015) 0.75
Time to Cooling Is Associated with Resuscitation Outcomes. Ther Hypothermia Temp Manag (2016) 0.75
Reply to: Therapeutic hypothermia after cardiac arrest: outcome predictors. Rev Bras Ter Intensiva (2016) 0.75
Cardiopulmonary resuscitation and management of cardiac arrest. Nat Rev Cardiol (2012) 0.75
Troponin Marker for Acute Coronary Occlusion and Patient Outcome Following Cardiac Arrest. West J Emerg Med (2015) 0.75
Dihydrocapsaicin-induced hypothermia after asphyxiai cardiac arrest in rats. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol (2010) 3.70
Early predictors of outcome in comatose survivors of ventricular fibrillation and non-ventricular fibrillation cardiac arrest treated with hypothermia: a prospective study. Crit Care Med (2008) 3.14
Early multimodal outcome prediction after cardiac arrest in patients treated with hypothermia. Crit Care Med (2014) 2.99
Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology (2009) 2.83
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol (2007) 2.81
Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Resuscitation (2014) 2.76
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation (2003) 2.56
The human K-complex represents an isolated cortical down-state. Science (2009) 2.54
Early EEG correlates of neuronal injury after brain anoxia. Neurology (2012) 2.53
From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med (2006) 2.48
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes (2002) 2.20
Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. Europace (2009) 2.07
The vasodilatory response of skin microcirculation to local heating is subject to desensitization. Microcirculation (2009) 2.02
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med (2006) 1.99
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med (2002) 1.97
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol (2009) 1.89
CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol (2007) 1.77
Management of mechanical ventilation in acute severe asthma: practical aspects. Intensive Care Med (2006) 1.76
Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med (2015) 1.70
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol (2004) 1.67
Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain. Intensive Care Med (2014) 1.64
Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med (2013) 1.60
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol (2010) 1.56
Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med (2011) 1.56
Accuracy of brain multimodal monitoring to detect cerebral hypoperfusion after traumatic brain injury*. Crit Care Med (2015) 1.55
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol (2007) 1.54
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol (2008) 1.51
Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51
Impact of low pulmonary vascular pressure on ventilator-induced lung injury. Crit Care Med (2002) 1.49
Psychogenic seizures and frontal disconnection: EEG synchronisation study. J Neurol Neurosurg Psychiatry (2011) 1.48
Detection of cerebral compromise with multimodality monitoring in patients with subarachnoid hemorrhage. Neurosurgery (2011) 1.46
Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock (2002) 1.44
Prognostic value of continuous EEG monitoring during therapeutic hypothermia after cardiac arrest. Crit Care (2010) 1.44
Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.43
Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med (2006) 1.42
Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium. Crit Care Med (2005) 1.40
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography. Circ J (2011) 1.40
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol (2007) 1.39
Pulse wave analysis of aortic pressure: diastole should also be considered. J Hypertens (2013) 1.39
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol (2002) 1.36
Refractory status epilepticus: a prospective observational study. Epilepsia (2009) 1.35
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol (2007) 1.34
A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther (2004) 1.32
Hypertension and microvascular remodelling. Cardiovasc Res (2008) 1.26
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med (2011) 1.24
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res (2002) 1.23
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res (2009) 1.22
Hypertension: a disease of the microcirculation? Hypertension (2006) 1.21
Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med (2006) 1.21
Predicting neurological outcome after cardiac arrest. Curr Opin Crit Care (2011) 1.20
Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem (2010) 1.19
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol Rep (2004) 1.18
Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia. Resuscitation (2013) 1.17
Rapid occurrence of depression following addition of sodium oxybate to modafinil. Sleep Med (2010) 1.17
Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem (2005) 1.13
Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol (2002) 1.12
Evaluation of an online, case-based interactive approach to teaching pathophysiology. Med Teach (2008) 1.10
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes (2012) 1.10
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology (2014) 1.09
Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res (2004) 1.08
The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep (2009) 1.07
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med (2008) 1.05
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis. Biochem Biophys Res Commun (2006) 1.04
Caspase-3 protects stressed organs against cell death. Mol Cell Biol (2012) 1.03
Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit (2004) 1.03
Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med (2002) 1.03
Acute seizures in acute ischemic stroke: does thrombolysis have a role to play? J Neurol (2012) 1.03
Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med (2012) 1.02
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.01
Magnetoencephalography demonstrates multiple asynchronous generators during human sleep spindles. J Neurophysiol (2010) 1.00
Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management. Crit Care (2012) 1.00
Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia (2011) 1.00
The role of oxidative stress during inflammatory processes. Biol Chem (2014) 0.99
Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation. J Cardiovasc Pharmacol (2004) 0.99
Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res (2013) 0.98